Analysts have set 12-month price targets for Allstate, revealing an average target of $216.88, a high estimate of $250.00, ...

Allstate Corporation ended 2024 on a high note, reporting strong financial and strategic performance in the fourth quarter and full year. The company posted $16.5 billion in total revenue for Q4 ...

Allstate's recent financial performance has been marked by both challenges and opportunities. The company reported substantial catastrophe losses in the third quarter of 2024, amounting to $1.70 ...

The Allstate Corporation ALL recently closed the sale of its Group Health business to Nationwide for a total consideration of ...

Morgan Stanley analyst Bob Huang has maintained their bullish stance on ALL stock, giving a Buy rating on October 18. Bob Huang has given his B ...

Allstate offers strong yields on preferreds and bonds, backed by solid ratings and insurer strength despite weather losses.

Allstate has shown improved performance post-2022-23 downturn but lacks strong future business ... Financial performance has been weak due to rising claims costs and catastrophe losses, ...

Allstate (ALL) closed the latest trading day at $190.79, indicating a -1.15% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 3.46% ...

Nevertheless, Allstate’s overall performance has remained more than impressive. The company reported a staggering 14.7% year-over-year growth in consolidated revenues to $16.6 billion.

Allstate Corp. closed 8.74% short of its 52-week high of $213.18, which the company achieved on June 3rd.

Nationwide has completed its $1.25 billion acquisition of The Allstate Corporation’s employer stop loss business, expanding its presence in the self-funded health benefits market. The deal closed as ...

For valuable insights into Allstate's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings ...